118 related articles for article (PubMed ID: 25634024)
1. An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing.
Jung JW; Kim DK; Park HW; Oh KH; Joo KW; Kim YS; Ahn C; Lee KW; Cho SH; Min KU; Kang HR
Genet Med; 2015 Oct; 17(10):807-14. PubMed ID: 25634024
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation of ITGB2 contributes to allopurinol hypersensitivity.
Liu Y; Wang CW; Chen CB; Yu KH; Wu YJ; Choon SE; Chang WC; Yang F; Luo XQ; Chung WH; Zhao M; Lu QJ
Clin Immunol; 2023 Mar; 248():109250. PubMed ID: 36738816
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide Study Identifies Association between HLA-B
Krebs K; Bovijn J; Zheng N; Lepamets M; Censin JC; Jürgenson T; Särg D; Abner E; Laisk T; Luo Y; Skotte L; Geller F; Feenstra B; Wang W; Auton A; ; Raychaudhuri S; Esko T; Metspalu A; Laur S; Roden DM; Wei WQ; Holmes MV; Lindgren CM; Phillips EJ; Mägi R; Milani L; Fadista J
Am J Hum Genet; 2020 Oct; 107(4):612-621. PubMed ID: 32888428
[TBL] [Abstract][Full Text] [Related]
4. HLA-A*24:02 increase the risk of allopurinol-induced drug reaction with eosinophilia and systemic symptoms in HLA-B*58:01 carriers in a Korean population; a multicenter cross-sectional case-control study.
Kim MY; Yun J; Kang DY; Kim TH; Oh MK; Lee S; Kang MG; Nam YH; Choi JH; Yang MS; Han SS; Lee H; Cho HJ; Yang J; Oh KH; Kim YS; Jung JW; Lee KH; Kang HR
Clin Transl Allergy; 2022 Sep; 12(9):e12193. PubMed ID: 36176736
[TBL] [Abstract][Full Text] [Related]
5. Implementing HLA-B*58:01 testing prior to allopurinol initiation in Malaysian primary care setting: A qualitative study from doctors' and patients' perspective.
Ng WL; Hussein N; Ng CJ; Qureshi N; Lee YK; Kwan Z; Kee BP; Then SM; Abdul Malik TF; Mohd Zaidan FZ; Azmi SUF
PLoS One; 2024; 19(1):e0296498. PubMed ID: 38206925
[TBL] [Abstract][Full Text] [Related]
6. Reducing severe cutaneous adverse and type B adverse drug reactions using pre-stored human leukocyte antigen genotypes.
Lee KH; Kang DY; Kim HH; Kim YJ; Kim HJ; Kim JH; Song EY; Yun J; Kang HR
Clin Transl Allergy; 2022 Jan; 12(1):e12098. PubMed ID: 35070271
[TBL] [Abstract][Full Text] [Related]
7. Rapid and Reliable
Huh JY; Song YJ; Park G
Ann Clin Lab Sci; 2024 Jan; 54(1):101-105. PubMed ID: 38514059
[TBL] [Abstract][Full Text] [Related]
8. Developing pharmacogenetic screening methods for an emergent country: Vietnam.
Nguyen DV; Vidal C; Chu HC; van Nunen S
World Allergy Organ J; 2019; 12(5):100037. PubMed ID: 31198488
[TBL] [Abstract][Full Text] [Related]
9. Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis.
Manson LEN; van den Hout WB; Guchelaar HJ
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056062
[TBL] [Abstract][Full Text] [Related]
10. Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions.
Manson LEN; Delwig SJ; Drabbels JJM; Touw DJ; De Vries APJ; Roelen DL; Guchelaar HJ
Front Genet; 2023; 14():1289015. PubMed ID: 37908589
[No Abstract] [Full Text] [Related]
11. Allopurinol-induziertes DRESS bei einem Han-Chinesen mit HLA-B*58:01: Allopurinol-induced DRESS in a Han Chinese patient with HLA-B*58:01.
Cramer N; Isik S; Forkel S; Schön MP; Buhl T
J Dtsch Dermatol Ges; 2024 Feb; 22(2):268-270. PubMed ID: 38361207
[No Abstract] [Full Text] [Related]
12. An association study of
Jiang M; Yang J; Yang L; Wang L; Wang T; Han S; Cheng Y; Chen Z; Su Y; Zhang L; Yang F; Chen SA; Zhang J; Xiong H; Wang L; Zhang Z; Ma L; Luo X; Xing Q
iScience; 2023 Aug; 26(8):107391. PubMed ID: 37554438
[TBL] [Abstract][Full Text] [Related]
13. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study.
Ko TM; Tsai CY; Chen SY; Chen KS; Yu KH; Chu CS; Huang CM; Wang CR; Weng CT; Yu CL; Hsieh SC; Tsai JC; Lai WT; Tsai WC; Yin GD; Ou TT; Cheng KH; Yen JH; Liou TL; Lin TH; Chen DY; Hsiao PJ; Weng MY; Chen YM; Chen CH; Liu MF; Yen HW; Lee JJ; Kuo MC; Wu CC; Hung SY; Luo SF; Yang YH; Chuang HP; Chou YC; Liao HT; Wang CW; Huang CL; Chang CS; Lee MT; Chen P; Wong CS; Chen CH; Wu JY; Chen YT; Shen CY;
BMJ; 2015 Sep; 351():h4848. PubMed ID: 26399967
[TBL] [Abstract][Full Text] [Related]
14. HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity.
Puangpetch A; Koomdee N; Chamnanphol M; Jantararoungtong T; Santon S; Prommas S; Hongkaew Y; Sukasem C
Front Genet; 2014; 5():478. PubMed ID: 25657656
[TBL] [Abstract][Full Text] [Related]
15. Understanding and improving the use of allopurinol in a teaching hospital.
Hmar RC; Kannangara DR; Ramasamy SN; Baysari MT; Williams KM; Day RO
Intern Med J; 2015 Apr; 45(4):383-90. PubMed ID: 25644128
[TBL] [Abstract][Full Text] [Related]
16. How do students react to analyzing their own genomes in a whole-genome sequencing course?: outcomes of a longitudinal cohort study.
Sanderson SC; Linderman MD; Zinberg R; Bashir A; Kasarskis A; Zweig M; Suckiel S; Shah H; Mahajan M; Diaz GA; Schadt EE
Genet Med; 2015 Nov; 17(11):866-74. PubMed ID: 25634025
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol Use and Risk of Fatal Hypersensitivity Reactions: A Nationwide Population-Based Study in Taiwan.
Yang CY; Chen CH; Deng ST; Huang CS; Lin YJ; Chen YJ; Wu CY; Hung SI; Chung WH
JAMA Intern Med; 2015 Sep; 175(9):1550-7. PubMed ID: 26193384
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic considerations in the treatment of gout.
Roberts RL; Stamp LK
Pharmacogenomics; 2015; 16(6):619-29. PubMed ID: 25876828
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the HLA-B
Park HW; Kim DK; Kim SH; Kim S; Chae DW; Yang MS; Oh YK; Lee JP; Jung JW; Shin J; Hwang JH; Kang MG; Kim SM; Kwon SK; Kim HY; Kim MH; Kim SJ; Ryu DR; Cho YJ; Jee YK; Kim SM; Lee EK; Kim JY; Cho HS; Jeong YY; Kim SH; Jun JB; Park JS; Kim GH; Kim S; Jung HY; Lee JM
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1271-1276. PubMed ID: 30580048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
